Patriot Financial Group Insurance Agency’s Trillium Therapeutics Inc. TRIL Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$35K	–	2313
2021 Q3	$35K	Hold	2,000	–	–	0.01%	1006
2021 Q2	$19K	Hold	2,000	–	–	﹤0.01%	1220
2021 Q1	$21K	Hold	2,000	–	–	﹤0.01%	1076
2020 Q4	$29K	Hold	2,000	–	–	0.01%	871
2020 Q3	$28K	Sell	2,000 -500	-20%	-$4.99K	0.01%	695
2020 Q2	$20K	Hold	2,500	–	–	0.01%	752
2020 Q1	$10K	Buy	+2,500	New	+$9.45K	﹤0.01%	872

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Patriot Financial Group Insurance Agency's TRIL Position: Q4 2021 in Review

Patriot Financial Group Insurance Agency sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 2,000 shares — an estimated $35K sold.

Patriot Financial Group Insurance Agency first reported a position in TRIL in Q1 2020 and held it in 7 quarters. The position peaked at $35K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Patriot Financial Group Insurance Agency reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 2,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $35K.
Patriot Financial Group Insurance Agency first reported a position in Trillium Therapeutics Inc. in Q1 2020 and held it in 7 quarters.
Patriot Financial Group Insurance Agency's Trillium Therapeutics Inc. position peaked at $35K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2021, filed 10 Jan 2022.